CVE-2026-35025ProFTPD through 1.3.9b and 1.3.10rc2 contains an access control bypass vulnerability that allows authenticated FTP users to circumvent Directory ACL restrictions by prefixing paths with /proc/self/ro…
Updated under an hour ago ()
Does this affect you?
It affects proftpd. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
ProFTPD through 1.3.9b and 1.3.10rc2 contains an access control bypass vulnerability that allows authenticated FTP users to circumvent Directory ACL restrictions by prefixing paths with /proc/self/root in the RNFR command handler. Attackers can exploit the unresolved symlink components in dir_canonical_path() to cause dir_check() to perform lexical path comparisons that match no configured Directory block, enabling rename operations on files in DenyAll-protected directories and subsequent retrieval of those files. Mitigation: Sessions configured with DefaultRoot (chroot) are not affected, as chroot changes the directory to which /proc/self/root resolves.
- CVSS
- 8.1 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-59
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jul 14, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
proftpd proftpd proftpd:proftpd | through 1.3.9b; 1.3.10; 1.3.10 | NVD |
References
- http://www.proftpd.org/product, release-notes
- https://github.com/proftpd/proftpd/issues/2170issue-tracking, mitigation
- https://www.vulncheck.com/advisories/proftpd-acl-bypass-via-proc-self-root-path-prefix-in-rnfrthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.